Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.19.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
REVENUES:    
Product revenue $ 16,842,456 $ 15,617,726
License revenue 142,834 142,834
Other revenue 0 7,000,000
Total Revenues 16,985,290 22,760,560
OPERATING EXPENSES:    
Cost of product revenue (exclusive of amortization expense shown below) 42,194,635 29,164,321
Research and development 3,926,120 5,570,029
Plasma center operating expenses 7,805,619 6,503,750
Asset impairment charge 0 845,389
Amortization of intangibles 844,938 1,234,674
Selling, general and administrative 22,502,922 18,752,393
Total operating expenses 77,274,234 62,070,556
LOSS FROM OPERATIONS (60,288,944) (39,309,996)
OTHER INCOME (EXPENSE):    
Interest income 195,403 57,228
Interest expense (5,522,783) (3,285,847)
Loss on extinguishment of debt 0 (1,210,216)
Other expense (127,121) (10,144)
Other expense, net (5,454,501) (4,448,979)
NET LOSS $ (65,743,445) $ (43,758,975)
BASIC AND DILUTED LOSS PER COMMON SHARE $ (1.45) $ (1.91)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: Basic and Diluted 45,188,899 22,896,042